Can We Predict Daily Adherence to Warfarin?: Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

BACKGROUND: Warfarin is the primary therapy to prevent stroke and venous thromboembolism. Significant periods of nonadherence frequently go unreported by patients and undetected by providers. Currently, no comprehensive screening tool exists to help providers assess the risk of nonadherence at the t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Platt, Alec B., Localio, A. Russell, Brensinger, Colleen M., Cruess, Dean G., Christie, Jason D., Gross, Robert, Parker, Catherine S., Price, Maureen, Metlay, Joshua P., Cohen, Abigail, Newcomb, Craig W., Strom, Brian L., Laskin, Mitchell S., Kimmel, Stephen E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American College of Chest Physicians 2010
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2851552/
https://ncbi.nlm.nih.gov/pubmed/19903973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0039
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi